BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 11500727)

  • 1. Serum cytokines levels in Graves' disease.
    Al-Humaidi MA
    Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
    Tang L; Luo Q; Zhou X; Xia R
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
    Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
    Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory cytokine levels in hyperthyroidism.
    Senturk T; Kozaci LD; Kok F; Kadikoylu G; Bolaman Z
    Clin Invest Med; 2003 Apr; 26(2):58-63. PubMed ID: 12722837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 polarization and low-T3 syndrome are correlated with hyperleptinemia in hemodialysis patients.
    Liu ML; Huang ZY; Zhong XC; Liu SH; Xu G; Jiang TY; Xi WW; Yan WQ
    J Nephrol; 2009; 22(4):515-22. PubMed ID: 19662608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
    Jacob SE; Nassiri M; Kerdel FA; Vincek V
    Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' disease.
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Crespillo-Gómez C; Berg J
    Horm Metab Res; 2003 Jul; 35(7):427-33. PubMed ID: 12931274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Organ-specific autoimmune diseases and cytokines].
    Hidaka Y; Amino N
    Rinsho Byori; 1999 Apr; 47(4):335-9. PubMed ID: 10340007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes and significance of TNF, sIL-2R, IL-6, IL-4 and IFN-gamma levels in plasma from the patients with hemorrhagic fever with renal syndrome].
    Liu JM; Zhu Y; Wang JP; Ouyang WM; Li Q; Zhuang R; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):744-6. PubMed ID: 15555451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.
    Lauerova L; Dusek L; Simickova M; Kocák I; Vagundová M; Zaloudík J; Kovarík J
    Neoplasma; 2002; 49(3):159-66. PubMed ID: 12098001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.